Sep 4 |
Applied Therapeutics: Pushing Towards FDA Approval
|
Sep 4 |
Applied Therapeutics to Participate in Upcoming Investor Conferences
|
Aug 7 |
Applied Therapeutics GAAP EPS of -$0.13
|
Aug 7 |
Applied Therapeutics Reports Second Quarter 2024 Financial Results
|
Aug 6 |
Applied Therapeutics, Inc. (NASDAQ:APLT): When Will It Breakeven?
|
Jul 31 |
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
|
Jul 1 |
Applied Therapeutics joins Russell 3000 Index
|
Jul 1 |
Applied Therapeutics Added to Russell 3000® Index
|
Jun 30 |
Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?
|
Jun 26 |
Here's Why We're Not Too Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
|